I offer strategic and clinically informed consulting at the intersection of psychiatry, neuroscience, and health innovation. My work supports organizations developing and implementing novel approaches to neuropsychiatric care, with a focus on:Â
Interventional Psychiatry
Guidance on clinical integration and evidence-based use of treatments such as TMS, ketamine, and psychedelic-assisted therapy.
Clinical & Scientific Strategy
Support for biotech, digital health, and healthcare organizations in designing clinical programs, protocols, and treatment models grounded in psychiatric expertise.
Translational Research & Innovation
Input on research direction, study design, and the application of emerging findings to real-world clinical contexts.
Ethical & Regulatory Advisory
Consultation on ethical frameworks for novel therapeutics, with attention to professional standards, patient safety, and regulatory alignment.
Program Development
Experience in building and scaling interventional psychiatry services within clinical systems and advising on operational models.